Lupus Research Alliance News
Two Studies Show COVID-19 Vaccines are Well-Tolerated Among Lupus Patients

August 12, 2021 In two recent studies, researchers found that the four COVID-19 vaccines are well-tolerated in lupus patients. Given that the Moderna and Pfizer vaccines are the first mRNA vaccines currently authorized for the emergency use in people, lupus researchers have since worked to answer questions specifically about potential side effects and whether these […] READ MORE

Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)

  First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY. August 2, 2021. The Lupus Research Alliance (LRA) is particularly excited about the U.S. Food and Drug Administration (FDA) approval of anifrolumab-fnia (Saphnelo™), a first-in-class type I interferon receptor antagonist indicated for adults with […] READ MORE

COVID-19 Took Significant Toll on People with Lupus

July 29, 2021 A new study showed that people with lupus experienced significant physical and emotional effects in the early months of the COVID-19 pandemic.   Including LRA Scientific Advisory Board member Jane Salmon, MD, researchers at Hospital for Special Surgery and Tufts University in Boston invited 97 patients to complete a questionnaire in the […] READ MORE

LRA’s Visionary Strategy to Turn Lupus Complexity to its Cure

July 15, 2021 Dear Friends, With much excitement, we introduce our new overarching approach to fulfilling LRA’s mission: Turning Complexity to Cure. Our goal is to involve the lupus community and beyond in our strategy to turn the core problem of lupus – its heterogeneity – how much it differs from person to person – into its solution through […] READ MORE

Congress Continues Support for Lupus Research Program at $10 Million  

July 12, 2021 Today the House Appropriations Committee released the fiscal year 2022 Defense Appropriations Bill with $10 million for the Lupus Research Program (LRP) in the Congressionally Directed Medical Research Programs operated under the Defense Health Program. We are thankful that Congress maintained the funding for this program, and we remain committed to advocating for steady and robust investment for this critical […] READ MORE

Learn and connect with our community!